Viewing Page 1 of 2 | Showing Results 1 - 10 of 17
This research trial studies the financial burden in patients with stage I-III colon or rectal cancer who are undergoing treatment. Collecting data...
Alison Conlin, M.D.
The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.
This randomized phase III trial studies combination chemotherapy and atezolizumab to see how well it works compared with combination chemotherapy...
Alison Conlin, M.D.
The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.
Inclusion Criteria:• Patients diagnosed with hepatocellular carcinoma of the liver and/or liver metastases• Able to provide informed consent• 18...
Rex Hoffman, M.D.
- Disney Family Cancer Center (DFCC)
- Providence Los Angeles Research Center
This phase III trial studies how well vitamin D3 given with standard chemotherapy and bevacizumab works in treating patients with colorectal cancer...
Alison Conlin, M.D.
The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.
This randomized phase II clinical trial studies how well nivolumab after combined modality therapy works in treating patients with high risk stage...
Alison Conlin, M.D.
The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.
The purpose of this study is to assess whether eflornithine 500 mg or sulindac 150 mg are effective in reducing the 3-year event rate of high risk...
Gary Goodman, M.D.
The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.
This phase III trial studies how well gemcitabine hydrochloride and cisplatin given with or without nab-paclitaxel work in treating patients with...
Gary Goodman, M.D.
The Pacific Cancer Research Consortium clinical trials are offered at multiple locations throughout Oregon, Washington, Alaska, California, and Idaho. To find a location near you, please contact the Patient Engagement Center at 844-552-2734.
The purpose of this study is to see how effective and safe LY2157299, in combination with chemotherapy and radiation therapy, might be in treating...
Kristina Young, M.D., Ph.D.
- Oncology and Hematology Care Westside
- Providence Cancer Institute Franz Clinic
- Providence Cancer Institute Newberg Clinic
- Providence Portland Medical Center
TARGET-HCC is a longitudinal, observational study of patients being managed for HCC in usual clinical practice. TARGET-HCC will create a research...
Philippa Newell, M.D.
- Oncology and Hematology Care Westside
- Providence Cancer Institute Franz Clinic
- TOC: GMIS, PPMC
The purpose of this study is to determine whether Nivolumab in combination with other therapies is more effective than Nivolumab in combination...
Gina Vaccaro, M.D.
- Oncology and Hematology Care Westside
- Providence Cancer Institute Franz Clinic
Viewing Page 1 of 2 | Showing Results 1 - 10 of 17